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Abstract
Background: Parkinson’s disease (PD) is frequently associated with brain vascular lesions (BVLs). Studies suggest that the latter may influence 
the severity of the disease.
Material and methods: BVLs on MRI were determined in 78.4% of 111 consecutive PD patients (mean age 64.87 ± 7.69 y.o.; disease duration 
50.21 ± 38.61 mo.; 48 women (43.2%), 63 men (56.8%)).
Results: White matter lesions were present in 73 patients (pts.) (65.77%):  61 pts. (54.95%) – deep white matter, 46 pts. (41.44%) – periventricular 
white matter, and 41pts. (36.94%) – both locations. Lacunes were determined in 19 pts. (17.12%), cerebral fissures deepening – 52 pts. (46.85) 
%), perivascular spaces dilation – 34 pts. (30.63%), ventricular system dilation – 29 pts. (26.13%). Patients with and without BVLs had similar 
ages (65.43 ± 7.64 vs 61.01 ± 7.64), ages at PD onset (60.95 ± 8.09 vs 56.01 ± 8.59) and disease duration (49.98 ± 36.76 vs 60.01 ± 52.31). They 
had insignificantly higher Beck (7.26 ± 5.62 vs 6.86 ± 4.34), PDQ3(Parkinson’s Disease Questionnaire) (59.71 ± 20.38 vs 51.94 ± 27.69) and NMS(Non Motor Symptoms) 
(75.06 ± 45.21 vs 71.67 ± 26.35) scores; and lower MoCA(Montreal Cognitive Assessment) scores (21.92 ± 4.25 vs 22.38 ± 4.57). QRISK3 scores (19.68 ± 16.16 
vs 12.90 ± 6.58) and levodopa equivalent daily dose (639.98 ± 223.05 vs 439.69 ± 404.87) were significantly higher in patients with BVLs. 
Conclusions: Brain vascular lesions were common in our PD patients, and were associated with higher QRISK3 scores, as well as with higher 
levodopa equivalent daily dose, suggesting more disease severity.
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Abstract
Background: Vascular risk factors (VRFs) are common in Parkinson’s disease (PD) patients. Studies suggest the association of VRFs with motor 
severity and cognitive decline in PD.
Material and methods: In 111 consecutive PD patients (mean age 64.87 ± 7.69 y.o.; disease duration 50.21 ± 38.61 mo.; 48 women (43.2%), 63 
men (56.8%)) VRFs were assessed by QRISK3scale.
Results: VRFs were present in 106 (95.5%) patients: HBP (High Blood Pressure) – 74 pts. (66.7%), dyslipidemia – 36 pts. (32.4%), DM (Diabetes Mellitus) – 20 
pts. (18.0%), previous stroke – 14 pts. (12.6%), atrial fibrillation – 12 pts. (10.8%), smoking – 32 pts. (28.8%). Mean VRFs number per patient 
was 2.62 ± 1.39. PD onset age (60.44 ± 8.11 vs 60.80 ± 12.79) and disease duration (50.54 ± 38.74 vs 43.20 ± 39.44) were similar in groups. 
PD+VRFs patients had higher UPDRSon (36.11 ± 12.19 vs 20.00 ± 6.98, p = 0.011) and akinesia-rigidity scores (0.75 ± 0.61 vs 0.38 ± 0.13, p = 
0.001). PDQ39(Parkinson’s Disease Questionnaire) (54.41 ± 27.67 vs 41.25 ± 20.16, p > 0.05) were higher, and MoCA (Montreal Cognitive Assessment) scores (21.64 ± 4.32 
vs 22.60 ± 3.29) lower. Significant differences were found for MoCA naming (2.79 ± 0.41 vs 3.00 ± 0.00, p = 0.001), MoCA abstracting (1.46 ± 0.67 vs 
2.0 ± 0.01, p = 0.001) and MoCA orientation (5.58 ± 0.99 vs 6.00 ± 0.01, p = 0.004) subscores.
Conclusions: The frequency of vascular risk factors was high in our PD patients, the most common being HBP. Their presence was associated 
with motor severity and changes in specific cognitive subscores.
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